ALMOTRIPTAN MALATE PDF

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Author: Malale Mezit
Country: Lesotho
Language: English (Spanish)
Genre: Love
Published (Last): 9 September 2012
Pages: 225
PDF File Size: 18.8 Mb
ePub File Size: 1.22 Mb
ISBN: 581-7-20795-153-6
Downloads: 21563
Price: Free* [*Free Regsitration Required]
Uploader: Bar

Almotriptan is contraindicated in patients who have received ergotamine-containing or ergot-type medications within 24 hours of almotriptan administration.

Axert (almotriptan malate) dose, indications, adverse effects, interactions from

Cinnamaldehyde Almotriptan may decrease the excretion rate of Cinnamaldehyde which could result in a higher serum level. Ifenprodil The risk or severity of adverse effects can be increased when Almotriptan is combined with Ifenprodil.

Monitor supine blood pressure. Bifonazole The metabolism of Almotriptan can be decreased when combined with Bifonazole. Almotriptan is a triptan drug for the treatment of migraine headaches. Cinacalcet The malaet of Almotriptan can be decreased when combined with Cinacalcet. Corticosterone The metabolism of Corticosterone can be decreased when combined with Almotriptan. Hydroxyprogesterone caproate The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Almotriptan.

Gestodene The metabolism of Gestodene can be decreased when combined with Almotriptan. The concomitant use of these agents with bromocriptine should be avoided. It is taken by mouth for the relief of migraine severity, from moderate mallate severe pain to mild or no pain.

Avoid or use almofriptan caution with other serotonergic drugs to prevent serotonin syndrome see Drug Interactions. If almotriptan dose adjustments are made, re-adjust the dose upon completion of telaprevir treatment. Dosing information Axert tablets are taken by mouth with water or other liquids. Concomitant use of almotriptan and atazanavir should be avoided in patients with renal or hepatic impairment. Clofazimine The alnotriptan of Almotriptan can be decreased when combined with Clofazimine.

Major Ombitasvir; paritaprevir; ritonavir may increase the systemic exposure of almotriptan. Eucalyptus oil Almotriptan may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.

  MANOSCRITTI ECONOMICO FILOSOFICI DEL 1844 PDF

Fluocortolone The metabolism of Fluocortolone can be decreased when combined with Almotriptan. Botulinum toxin type A The risk or severity of adverse effects can be increased when Botulinum Toxin Type A is combined with Almotriptan. Individuals with the above conditions should be monitored closely while taking Axert. The information on this page has been compiled for use by healthcare practitioners and consumers in the United States and therefore neither Everyday Health or its licensor warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise.

Abiraterone The metabolism of Almotriptan can be decreased when combined with Abiraterone. Exemestane The metabolism of Exemestane can be decreased when combined with Almotriptan. Fludeoxyglucose F Almotriptan may decrease almotrkptan excretion rate of Fludeoxyglucose F which could result in a higher serum level.

For additional details, read the full prescribing information of Axert.

Eprosartan The risk or severity of hypertension can be increased when Eprosartan is combined with Almotriptan. Frovatriptan The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Frovatriptan. Major Because of the potential risk and severity of serotonin syndrome, caution should be observed when administering selective serotonin reuptake inhibitors SSRIs with other drugs that have serotonergic properties such as serotonin-receptor agonists e.

Views Read Edit View history. Chloramphenicol The metabolism of Almotriptan can be decreased when combined with Chloramphenicol. Flunarizine The risk or severity of adverse effects can be increased when Almotriptan is combined with Flunarizine.

Hydroxyurea The metabolism of Almotriptan can be decreased when combined with Hydroxyurea. Moderate Use caution if almotriptan and aprepitant, fosaprepitant are used concurrently and monitor for an increase in almotriptan-related adverse effects for several days after administration of a multi-day aprepitant regimen.

Intermittent hemodialysis See dosage for renal impairment. Since rasagiline selectively inhibits MAO-B at recommended doses, no interaction with almotriptan would be expected with normal prescription use. Bepridil The metabolism of Bepridil can be decreased when combined with Almotriptan. Azapropazone Azapropazone may decrease the excretion rate of Almotriptan which could result in a higher serum level.

  E5EK OMRON PDF

Patients receiving vilazodone and a serotonin-receptor agonist should be monitored for the emergence of serotonin syndrome, particularly during treatment initiation and during dosage increases. Hydrocortisone phosphate The metabolism of Almotriptan can be increased when combined with Hydrocortisone phosphate.

Bevantolol The metabolism of Bevantolol can be decreased when combined with Almotriptan. Aprindine The metabolism of Aprindine can be decreased when combined with Almotriptan.

Axert® (almotriptan malate)

Arotinolol Almotriptan may decrease the excretion rate of Arotinolol which could result in a higher serum level. Hygromycin B Hygromycin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. Doxorubicin The metabolism of Almotriptan can be decreased when combined with Doxorubicin.

Aldesleukin The metabolism of Almotriptan can be decreased when combined with Aldesleukin. Elderly patients are more likely to have unrecognized risk factors for coronary artery disease than younger adults. Cabergoline Cabergoline may increase the vasoconstricting activities of Almotriptan. Cyclobarbital The risk or severity of adverse effects can be increased when Almotriptan is combined with Cyclobarbital. Moderate No dosage adjustment is required in patients receiving letermovir with almotriptan who are not also receiving cyclosporine.

Clinical monitoring for adverse effects, such as serotonergic excess and triptan-related side effects, is recommended during coadministration. Alogliptin Almotriptan may decrease the excretion rate of Alogliptin which could result in a higher serum level.

Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Almotriptan. Acrivastine Almotriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Dextran Almotriptan may decrease the excretion rate of Dextran which could result in a higher serum level. Major Concurrent use of opioids with other drugs that modulate serotonergic function, such as selective serotonin-receptor agonists ‘triptans’has resulted in serotonin syndrome in some cases.